title: STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.
authors.affiliation: Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK.
authors.forename: Nicholas D
authors.initials: ND
authors.lastname: James
authors.affiliation: Medical Research Council, Clinical Trials Unit, University College London, London WC2B 6NH, UK. Electronic address: m.sydes@ucl.ac.uk.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Sydes
authors.affiliation: Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK.
authors.forename: Noel W
authors.initials: NW
authors.lastname: Clarke
authors.affiliation: Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK.
authors.forename: Malcolm D
authors.initials: MD
authors.lastname: Mason
authors.affiliation: Medical Research Council, Clinical Trials Unit, University College London, London WC2B 6NH, UK.
authors.forename: Mahesh K B
authors.initials: MK
authors.lastname: Parmar
mesh_terms: D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004164:Diphosphonates / Q000008:administration & dosage*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; D007093:Imidazoles; D043823:Taxoids